Search

everythinglearnresearchcommunity

for

Search:↓

Taking fluconazole for fungal infections might cause hair loss after about 3 months.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Hair loss in a child was an early sign of Crohn's disease.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

The 675-nm diode laser may safely help treat telogen effluvium.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Managing telogen effluvium is challenging due to limited scientific evidence.

Omega-3 fatty acids may help manage hair loss in middle-aged women.

A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.

A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

People with Telogen Effluvium often lack vitamin D, ferritin, and zinc.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Accurate diagnosis of hair loss types is crucial for effective treatment.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

Iron deficiency is linked to a common type of hair loss called telogen effluvium.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

A man's skin condition was misdiagnosed and later identified as a rare type of skin cancer, which did not improve with treatment.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Tislelizumab can cause cutaneous lupus erythematosus.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

COVID-19 may increase hair loss due to stress and inflammation.

The chapter concludes that certain skin diseases in bovines cause symmetrical, non-painful lesions and temporary hair loss due to stress.